Skip to main content
Erschienen in: World Journal of Surgery 1/2014

01.01.2014

The Impact of Posthepatectomy Liver Failure on the Recurrence of Hepatocellular Carcinoma

verfasst von: Kohta Iguchi, Etsuro Hatano, Kenya Yamanaka, Shiro Tanaka, Kojiro Taura, Shinji Uemoto

Erschienen in: World Journal of Surgery | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with hepatocellular carcinoma (HCC) who underwent hepatectomy often developed an intrahepatic recurrence, even though it was a curative one. The relationship between surgery-induced liver damage and the recurrence of HCC has not been described. This study evaluated whether posthepatectomy liver failure, as defined by the International Study Group of Liver Surgery, affected the recurrence of HCC.

Methods

We performed a retrospective cohort study of 488 patients with HCC who underwent hepatectomy between 2004 and 2012 at Kyoto University Hospital. Early posthepatectomy liver failure (EPLF) was defined as liver failure occurring between postoperative days 5 and 10. The patients were divided into an EPLF group and a non-EPLF group. Disease-free survival (DFS) was compared between these groups. The influences of host-related, surgery-related, and tumor-related factors on patient outcomes were evaluated using multivariate analyses.

Results

The EPLF group and the non-EPLF group contained 153 and 335 patients, respectively. The probability of DFS was significantly increased in the non-EPLF group (median: 574 days) compared to the EPLF group (median: 348 days) (hazard ratio, HR [95 % confidence interval, CI] 1.61 [1.29–2.00]). The multivariate analysis revealed that EPLF was an independent factor for DFS (HR [95 % CI] 1.43 [1.13–1.81]), besides the factors previously described, including fibrosis (1.32 [1.05–1.67]), stage (1.85 [1.34–2.51]), tumor differentiation (1.46 [1.11–1.89]), and des-γ-carboxyprothrombin (1.39 [1.10–1.74]).

Conclusions

EPLF was associated with postoperative HCC recurrence. The prevention of EPLF might improve the prognosis of patients with HCC.
Literatur
1.
2.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J et al (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J et al (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
3.
Zurück zum Zitat Kudo M (2011) Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology 81(Suppl 1):73–85PubMedCrossRef Kudo M (2011) Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology 81(Suppl 1):73–85PubMedCrossRef
4.
Zurück zum Zitat Narita M, Hatano E, Arizono S et al (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798PubMedCrossRef Narita M, Hatano E, Arizono S et al (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798PubMedCrossRef
5.
Zurück zum Zitat Cescon M, Vetrone G, Grazi GL et al (2009) Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249:995–1002PubMedCrossRef Cescon M, Vetrone G, Grazi GL et al (2009) Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249:995–1002PubMedCrossRef
6.
Zurück zum Zitat Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef
7.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–407PubMedCrossRef Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–407PubMedCrossRef
8.
Zurück zum Zitat Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48:S20–S37PubMedCrossRef Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48:S20–S37PubMedCrossRef
9.
Zurück zum Zitat Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724PubMedCrossRef Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724PubMedCrossRef
10.
Zurück zum Zitat Lo CM, Fan ST, Liu CL et al (2007) Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94:78–86PubMedCrossRef Lo CM, Fan ST, Liu CL et al (2007) Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94:78–86PubMedCrossRef
11.
Zurück zum Zitat van der Bilt JDW, Kranenburg O, Nijkamp MW et al (2005) Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 42:165–175PubMedCrossRef van der Bilt JDW, Kranenburg O, Nijkamp MW et al (2005) Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 42:165–175PubMedCrossRef
12.
Zurück zum Zitat Man K, Ng KT, Lo CM et al (2007) Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases: activation of cell invasion and migration pathways. Liver Transpl 13:1669–1677PubMedCrossRef Man K, Ng KT, Lo CM et al (2007) Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases: activation of cell invasion and migration pathways. Liver Transpl 13:1669–1677PubMedCrossRef
13.
Zurück zum Zitat Man K, Lo CM, Xiao JW et al (2008) The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 247:1049–1057PubMedCrossRef Man K, Lo CM, Xiao JW et al (2008) The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 247:1049–1057PubMedCrossRef
14.
Zurück zum Zitat Yamamoto K, Yamanaka K, Hatano E et al (2012) An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records. Clin Trials 9(4):408–417PubMedCrossRef Yamamoto K, Yamanaka K, Hatano E et al (2012) An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records. Clin Trials 9(4):408–417PubMedCrossRef
15.
Zurück zum Zitat Couinaud C (1954) Lobes et segments hepatiques—notes sur larchitecture anatomique et chirurgicale du foie. Presse Med 62:709–712PubMed Couinaud C (1954) Lobes et segments hepatiques—notes sur larchitecture anatomique et chirurgicale du foie. Presse Med 62:709–712PubMed
16.
Zurück zum Zitat Yamamoto Y, Ikai I, Kitai T et al (1996) Reevaluation of hepatic functional reserve using ICG clearance rate in the major hepatectomy without vascular occlusion. In: Kim JP, Condon RE (eds). Bologna: Monduzzi Editore Yamamoto Y, Ikai I, Kitai T et al (1996) Reevaluation of hepatic functional reserve using ICG clearance rate in the major hepatectomy without vascular occlusion. In: Kim JP, Condon RE (eds). Bologna: Monduzzi Editore
17.
Zurück zum Zitat Owens WD, Felts JA, Spitznagel EL (1978) ASA physical status classifications—study of consistency of ratings. Anesthesiology 49:239–243PubMedCrossRef Owens WD, Felts JA, Spitznagel EL (1978) ASA physical status classifications—study of consistency of ratings. Anesthesiology 49:239–243PubMedCrossRef
18.
Zurück zum Zitat Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293PubMedCrossRef Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293PubMedCrossRef
19.
Zurück zum Zitat Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed
20.
Zurück zum Zitat Hasegawa K, Kokudo N, Imamura H et al (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252–259PubMedCrossRef Hasegawa K, Kokudo N, Imamura H et al (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252–259PubMedCrossRef
21.
Zurück zum Zitat Liu CL, Fan ST, Lo CM et al (2000) Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 232:25–31PubMedCrossRef Liu CL, Fan ST, Lo CM et al (2000) Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 232:25–31PubMedCrossRef
22.
Zurück zum Zitat Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665PubMedCrossRef Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665PubMedCrossRef
23.
Zurück zum Zitat Liver Cancer Study Group of Japan (2009) The general rules for the clinical and pathological study of primary liver cancer. Kanehara, Tokyo Liver Cancer Study Group of Japan (2009) The general rules for the clinical and pathological study of primary liver cancer. Kanehara, Tokyo
24.
Zurück zum Zitat Fan ST, Ng IOL, Poon RTP et al (1999) Hepatectomy for hepatocellular carcinoma—the surgeon’s role in long-term survival. Arch Surg 134:1124–1130PubMedCrossRef Fan ST, Ng IOL, Poon RTP et al (1999) Hepatectomy for hepatocellular carcinoma—the surgeon’s role in long-term survival. Arch Surg 134:1124–1130PubMedCrossRef
25.
Zurück zum Zitat Poon RTP, Fan ST, Ng IOL et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507PubMedCrossRef Poon RTP, Fan ST, Ng IOL et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507PubMedCrossRef
26.
Zurück zum Zitat Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207PubMedCrossRef Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207PubMedCrossRef
27.
Zurück zum Zitat Minagawa M, Ikai I, Matsuyama Y et al (2007) Staging of hepatocellular carcinoma—assessment of the Japanese TNM and AICCIUICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922PubMedCrossRef Minagawa M, Ikai I, Matsuyama Y et al (2007) Staging of hepatocellular carcinoma—assessment of the Japanese TNM and AICCIUICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922PubMedCrossRef
28.
Zurück zum Zitat Choi KK, Kim SH, Choi SB et al (2011) Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 26:1646–1651PubMedCrossRef Choi KK, Kim SH, Choi SB et al (2011) Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 26:1646–1651PubMedCrossRef
29.
Zurück zum Zitat Tsai TJ, Chau GY, Lui WY et al (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608PubMedCrossRef Tsai TJ, Chau GY, Lui WY et al (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608PubMedCrossRef
30.
Zurück zum Zitat AJCC (2009) AJCC Cancer Staging Manual. Springer, New York AJCC (2009) AJCC Cancer Staging Manual. Springer, New York
31.
Zurück zum Zitat Poon RTP, Fan ST, Ng IOL et al (2000) Significance of resection margin in hepatectomy for hepatocellular carcinoma—a critical reappraisal. Ann Surg 231:544–551PubMedCrossRef Poon RTP, Fan ST, Ng IOL et al (2000) Significance of resection margin in hepatectomy for hepatocellular carcinoma—a critical reappraisal. Ann Surg 231:544–551PubMedCrossRef
32.
Zurück zum Zitat Chau GY, Lui WY, Tsay SH et al (1997) Prognostic significance of surgical margin in hepatocellular carcinoma resection: An analysis of 165 Childs’ A patients. J Surg Oncol 66:122–126PubMedCrossRef Chau GY, Lui WY, Tsay SH et al (1997) Prognostic significance of surgical margin in hepatocellular carcinoma resection: An analysis of 165 Childs’ A patients. J Surg Oncol 66:122–126PubMedCrossRef
33.
Zurück zum Zitat Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623PubMedCrossRef Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623PubMedCrossRef
34.
Zurück zum Zitat Kosuge T, Makuuchi M, Takayama T et al (1993) Long-term results after resection of hepatocellular-carcinoma—experience of 480 cases. Hepatogastroenterology 40:328–332PubMed Kosuge T, Makuuchi M, Takayama T et al (1993) Long-term results after resection of hepatocellular-carcinoma—experience of 480 cases. Hepatogastroenterology 40:328–332PubMed
35.
Zurück zum Zitat Hammond JS, Guha IN, Beckingham IJ et al (2011) Prediction, prevention and management of postresection liver failure. Br J Surg 98:1188–1200PubMedCrossRef Hammond JS, Guha IN, Beckingham IJ et al (2011) Prediction, prevention and management of postresection liver failure. Br J Surg 98:1188–1200PubMedCrossRef
36.
Zurück zum Zitat Clavien P, Petrowsky H, DeOliveira ML et al (2007) Medical progress: Strategies for safer liver surgery and partial liver transplantation. New Engl J Med 356:1545–1559PubMedCrossRef Clavien P, Petrowsky H, DeOliveira ML et al (2007) Medical progress: Strategies for safer liver surgery and partial liver transplantation. New Engl J Med 356:1545–1559PubMedCrossRef
37.
Zurück zum Zitat Zhou WP, Lai ECH, Li AJ et al (2009) A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249:195–202PubMedCrossRef Zhou WP, Lai ECH, Li AJ et al (2009) A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249:195–202PubMedCrossRef
38.
Zurück zum Zitat Yoo H, Kim JH, Ko GY et al (2011) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 18:1251–1257PubMedCrossRef Yoo H, Kim JH, Ko GY et al (2011) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 18:1251–1257PubMedCrossRef
39.
Zurück zum Zitat Liu CL, Fan ST, Cheung ST et al (2006) Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma—a prospective randomized controlled study. Ann Surg 244:194–203PubMedCrossRef Liu CL, Fan ST, Cheung ST et al (2006) Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma—a prospective randomized controlled study. Ann Surg 244:194–203PubMedCrossRef
40.
Zurück zum Zitat Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475PubMedCrossRef Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475PubMedCrossRef
41.
Zurück zum Zitat Yamanaka K, Hatano E, Narita M et al (2011) Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model liver. Transplantation 17:60–69 Yamanaka K, Hatano E, Narita M et al (2011) Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model liver. Transplantation 17:60–69
42.
Zurück zum Zitat Yamanaka K, Hatano E, Iguchi K et al (2013) Effect of olprinone on liver microstructure in rat partial liver transplantation. J Surg Res 183:391–396PubMedCrossRef Yamanaka K, Hatano E, Iguchi K et al (2013) Effect of olprinone on liver microstructure in rat partial liver transplantation. J Surg Res 183:391–396PubMedCrossRef
Metadaten
Titel
The Impact of Posthepatectomy Liver Failure on the Recurrence of Hepatocellular Carcinoma
verfasst von
Kohta Iguchi
Etsuro Hatano
Kenya Yamanaka
Shiro Tanaka
Kojiro Taura
Shinji Uemoto
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 1/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2247-7

Weitere Artikel der Ausgabe 1/2014

World Journal of Surgery 1/2014 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.